Narita, Japan

Kinichi Mogi


Average Co-Inventor Count = 5.7

ph-index = 4

Forward Citations = 56(Granted Patents)


Location History:

  • Abiko, JP (1984 - 1990)
  • Chiba, JP (1996 - 1999)
  • Narita, JP (1993 - 2002)

Company Filing History:


Years Active: 1984-2002

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Kinichi Mogi: Innovator in Pharmaceutical Chemistry

Introduction

Kinichi Mogi is a prominent inventor based in Narita, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 12 patents to his name, Mogi has established himself as a key figure in the development of new pharmaceutical compounds.

Latest Patents

Mogi's latest patents include groundbreaking work on 4-hydroxy-4-phenylpiperidine derivatives and pharmaceuticals containing the same. He has also developed substituted quinolone derivatives and pharmaceuticals that exhibit excellent anti-ulcer activities. These derivatives are represented by specific chemical formulas, showcasing Mogi's expertise in creating effective pharmaceutical solutions.

Career Highlights

Throughout his career, Mogi has worked with notable companies such as Ss Pharmaceutical Co., Ltd. and Ssp Co., Ltd. His work has been instrumental in advancing pharmaceutical research and development, leading to the creation of innovative products that address various medical needs.

Collaborations

Mogi has collaborated with esteemed colleagues, including Susumu Sato and Hiroyuki Mizuno. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical chemistry.

Conclusion

Kinichi Mogi's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the industry positively, paving the way for future innovations in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…